FTL008.16
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FTL008.16, covering 2025-07-01 to 2025-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16 [Phase 1]